167 related articles for article (PubMed ID: 10973461)
1. Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period.
Rauprich P; Möller O; Walter G; Herting E; Robertson B
Clin Diagn Lab Immunol; 2000 Sep; 7(5):817-22. PubMed ID: 10973461
[TBL] [Abstract][Full Text] [Related]
2. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits.
Sherman MP; Campbell LA; Merritt TA; Long WA; Gunkel JH; Curstedt T; Robertson B
J Pediatr; 1994 Dec; 125(6 Pt 1):939-47. PubMed ID: 7996369
[TBL] [Abstract][Full Text] [Related]
3. Effects of different surfactant preparations on bacterial growth in vitro.
Neumeister B; Woerndle S; Bartmann P
Biol Neonate; 1996; 70(2):128-34. PubMed ID: 8864432
[TBL] [Abstract][Full Text] [Related]
4. Influence of modified natural and synthetic surfactant preparations on bacterial killing by polymorphonuclear leucocytes.
Rauprich P; Walter G; Jarstrand C; Robertson B; Herting E
Immunobiology; 2004; 209(8):609-17. PubMed ID: 15638129
[TBL] [Abstract][Full Text] [Related]
5. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
[TBL] [Abstract][Full Text] [Related]
6. The effect of three surfactant preparations on in vitro lymphocyte functions.
Woerndle S; Bartmann P
J Perinat Med; 1994; 22(2):119-28. PubMed ID: 7965541
[TBL] [Abstract][Full Text] [Related]
7. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
[TBL] [Abstract][Full Text] [Related]
8. Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits.
Corcoran JD; Berggren P; Sun B; Halliday HL; Robertson B; Curstedt T
Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F165-9. PubMed ID: 7820710
[TBL] [Abstract][Full Text] [Related]
9. Effects of perfluorocarbons and perfluorocarbons/surfactant emulsions on growth and viability of group B streptococci and Escherichia coli.
Rüdiger M; Köpke U; Prösch S; Rauprich P; Wauer RR; Herting E
Crit Care Med; 2001 Sep; 29(9):1786-91. PubMed ID: 11546986
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
[TBL] [Abstract][Full Text] [Related]
11. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
[TBL] [Abstract][Full Text] [Related]
12. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
da Costa DE; Pai MG; Al Khusaiby SM
Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
[TBL] [Abstract][Full Text] [Related]
13. Effect of exogenous surfactant on the development of surfactant synthesis in premature rabbit lung.
Amato M; Petit K; Fiore HH; Doyle CA; Frantz ID; Nielsen HC
Pediatr Res; 2003 Apr; 53(4):671-8. PubMed ID: 12612208
[TBL] [Abstract][Full Text] [Related]
14. Overview of clinical trials comparing natural and synthetic surfactants.
Halliday HL
Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
16. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses.
Thomassen MJ; Antal JM; Connors MJ; Meeker DP; Wiedemann HP
Am J Respir Cell Mol Biol; 1994 Apr; 10(4):399-404. PubMed ID: 8136155
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial examining cerebral haemodynamics following artificial or animal surfactant.
Murdoch E; Kempley ST
Acta Paediatr; 1998 Apr; 87(4):411-5. PubMed ID: 9628297
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical responses to natural and synthetic surfactants.
Rollins M; Jenkins J; Tubman R; Corkey C; Wilson D
J Perinat Med; 1993; 21(5):341-7. PubMed ID: 8126629
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of exogenous surfactant to phospholipase A2 degradation.
Duncan JE; Hatch GM; Belik J
Can J Physiol Pharmacol; 1996 Aug; 74(8):957-63. PubMed ID: 8960386
[TBL] [Abstract][Full Text] [Related]
20. Serial phospholipid analysis in preterm infants: comparison of Exosurf and Survanta.
Lloyd J; Todd DA; John E
Early Hum Dev; 1999 Mar; 54(2):157-68. PubMed ID: 10213294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
